(Press-News.org) Scientists believe a new treatment, shown to be effective in mice, could halt the growth of tumours in patients with prostate cancer.
Pioneering research, by academics at the Universities of Bristol, Nottingham and the University of the West of England (UWE Bristol), shows that a specific compound can inhibit the activity of a molecule which is key to how tumours form new blood vessels. The vessels are essential for the cancer cells to survive and multiply.
The findings, published today [10 November] in the journal Oncogene, show that targeting a molecule called SRPK1 could stop progression of prostate cancer.
SRPK1 plays a vital role in 'angiogenesis' - an essential process through which tumours are able to form blood vessels and obtain necessary nutrients to fuel their growth.
This process is mainly regulated by VEGF - vascular endothelial growth factor - which can activate or inhibit vessel formation depending on how the gene is controlled by a cellular process called 'alternative splicing'.
By analysing samples of human prostate cancer, researchers observed that SRPK1 increases as the cancer gets more aggressive.
Dr Sebastian Oltean, the study's co-author from the University of Bristol's School of Physiology and Pharmacology, said: "We reasoned that inhibition of SRPK1 activity could stop cancer progression. Indeed, we show in this paper that if we decrease SRPK1 levels in prostate cancer cells, or in tumours grafted into mice, we are able to switch VEGF splicing and therefore inhibit tumour vasculature and growth."
Researchers showed that drugs known as SPHINX compounds, designed to inhibit specifically the activity of SRPK1, are able to decrease tumour growth in a mouse model of prostate cancer when given three times weekly by injections.
Professor David Bates, co-author from the University of Nottingham's Division of Cancer and Stem Cells, said: "Our results point to a novel way of treating prostate cancer patients and may have wider implications to be used in several types of cancers."
Biotech company Exonate, a spin-out drug development company from the University of Nottingham, aims to develop SRPK1 inhibitors as treatments for diseases with abnormal vessel development such age-related macular degeneration and cancer.
This study has been funded by Prostate Cancer UK, the Biotechnology and Biological Sciences Research Council (BBSRC) and Richard Bright VEGF Research Trust.
Dr Matthew Hobbs, Deputy Director of Research at Prostate Cancer UK, said: "There's no denying that there are too few treatment options for the 40,000 men that face a diagnosis of prostate cancer every year in the UK - especially for those with advanced disease. Prostate cancer continues to kill over 10,000 men annually and there is an urgent need for new treatments if we are to significantly reduce this figure.
"Although it's early days, each finding like this represents a crucial block in building up our understanding of what can slow down and stop the progression of prostate cancer. This understanding will give us the foundations needed to develop new targeted treatments for those men in desperate need."
INFORMATION:
'Serine arginine protein kinase-1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer' by Athina Mavrou, Karen Brakspear, Maryam Hamdollah-Zadeh, Gopinath Damodaran, Roya Babaei-Jadidi, Jon Oxley, David A Gillatt, Michael R Ladomery, Steven J Harper, David O Bates and Sebastian Oltean in Oncogene.
The sound of monitor alarms in hospitals can save patients' lives, but the frequency with which the monitors go off can also lead to "alarm fatigue," in which caregivers become densensitized to the ubiquitous beeping.
Researchers at Cincinnati Children's Hospital Medical Center have tackled this problem and developed a standardized, team-based approach to reducing cardiac monitor alarms. The process reduced the median number of daily cardiac alarms from 180 to 40, and increased caregiver compliance with the process from 38 percent to 95 percent.
"Cardiac monitors ...
Laundry detergent pods began appearing on U.S. store shelves in early 2010, and people have used them in growing numbers ever since. The small packets can be tossed into a washing machine without ever having to measure out a liquid or powder. The convenience, though, has come with risks for young children.
A new study from researchers at Nationwide Children's Hospital found that from 2012 through 2013, U.S. poison control centers received reports of 17,230 children younger than 6 years of age swallowing, inhaling, or otherwise being exposed to chemicals in laundry detergent ...
When bladder cancer patients are well-informed by their physicians, they acknowledge that tobacco use was likely the cause of their disease. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. Patients with such knowledge may be more motivated to quit smoking, which could help prolong their lives.
At least half of bladder cancer cases diagnosed in the United States are the result of cigarette smoking. Bladder cancer is the second most common tobacco-related malignancy, a fact that is not well known ...
Businesses report that U.S. military veterans make excellent employees, but companies still experience challenges locating and hiring them, according to a new RAND Corporation report.
Studying a group of companies that have made a major commitment to hire veterans, researchers concluded that challenges remain for veterans seeking civilian jobs and employers hoping to hire them, including continuing difficulty understanding the match between military skills and civilian job requirements.
Too often veterans believe their talents apply only in the security or defense ...
The child-mortality gap has narrowed between the poorest and wealthiest households in a majority of more than 50 developing countries, a new study from the Stanford University School of Medicine has found.
This convergence was mostly driven by the fact that child-mortality rates declined the fastest among the poorest families. In the countries where the gap increased, the study identified a common thread: poor governance.
The findings provide important information for making decisions about prioritizing global health investments to effectively promote equity, said ...
JACKSONVILLE, Fla. -- Researchers at Mayo Clinic's campus in Jacksonville say they have identified first steps in the origin of pancreatic cancer and that their findings suggest preventive strategies to explore.
In an online issue of Cancer Discovery, the scientists described the molecular steps necessary for acinar cells in the pancreas -- the cells that release digestive enzymes -- to become precancerous lesions. Some of these lesions can then morph into cancer.
"Pancreatic cancer develops from these lesions, so if we understand how these lesions come about, we may ...
This news release is available in French.
VIDEO:
Arthritis pain in dogs can be relieved, with no side effects, by a new product based on medicinal plants and dietary supplements that was developed at the University of Montreal's...
Click here for more information.
Arthritis pain in dogs can be relieved, with no side effects, by a new product based on medicinal plants and dietary ...
A team of researchers led by Michele Fumagalli from the Extragalactic Astronomy Group and the Institute for Computational Cosmology at Durham University, were among the first to use ESO's Multi Unit Spectroscopic Explorer (MUSE) instrument on the VLT. Observing ESO 137-001 -- a spiral galaxy 200 million light-years away in the southern constellation of Triangulum Australe (The Southern Triangle) -- they were able to get the best view so far of exactly what is happening to the galaxy as it hurtles into the Norma Cluster.
MUSE gives astronomers not just a picture, but provides ...
Dublin, Ireland, November 9th 2014 - Botanists at Trinity College Dublin have launched a database with information that documents significant 'life events' for nearly 600 plant species across the globe. They clubbed together with like-minded individuals working across five different continents to compile the huge database of plant life histories, for which data have been gathered over a near 50-year span.
At a time in which climate change and increasing human populations are rapidly re-shaping plant distributions, the researchers hope their COMPADRE Plant Matrix database ...
Bobbing your head, tapping your heel, or clapping along with the music is a natural response for most people, but what about those who can't keep a beat?
Researchers at McGill University and the University of Montreal, have discovered that beat-deafness, though very rare, is a problem not simply of how people feel a pulse or move their bodies, but instead, how people synchronize with sounds they hear.
"We examined beat tracking, the ability to find a regular pulse and move with it, in individuals who complained of difficulty following a beat in everyday activities ...
